Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has provided an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced its proposal to enter into a lease agreement with Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. The agreement involves leasing a property in Tianjin for warehouse use, aiming to enhance asset utilization efficiency. The lease term is set for three years, starting from July 2025, with a total rent of RMB14,785,800. This transaction represents a strategic move to optimize the company’s existing resources and improve operational efficiency.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on leveraging its assets and resources efficiently.
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.